EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity



Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity



Journal of Thrombosis and Haemostasis 10(9): 1938-1943



Rare Bleeding Disorders (RBDs) include the inherited deficiencies of coagulation factors including fibrinogen, factor (F)II, FV, FV+FVIII, FVII, FX, FXI and FXIII, and are usually transmitted as autosomal recessive disorders [1]. Due to their rarity, they sometimes present significant challenges in diagnosis and treatment [2]. The development of guidelines for classification and treatment for these disorders has been hampered by a lack of sufficient knowledge about epidemiology and clinical outcomes, the difficulty in recognizing affected patients and collecting longitudinal clinical data, the limits of laboratory assays, and a lack of consensus concerning the criteria by which these disorders are classified. A collaboration among experts on RBDs was therefore proposed.

(PDF emailed within 0-6 h: $19.90)

Accession: 036492714

Download citation: RISBibTeXText

PMID: 22943259

DOI: 10.1111/j.1538-7836.2012.04844.x



Related references

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. Journal of Thrombosis and Haemostasis 10(4): 615-621, 2012

Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review. Plos One 9(9): E108683-E108683, 2015

Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders. Acta Haematologica 133(2): 148-154, 2015

Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders. Haemophilia, 2018

Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders. Pathophysiology of Haemostasis and Thrombosis 34(6): 279-283, 2006

Influence of factor VHR2 on thrombin generation and clinical manifestation in rare bleeding disorders. Pathophysiology of Haemostasis and Thrombosis 34(6): 279-283, 2005

Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia 18(3): E195-E200, 2012

Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 65(3): 719-724, 1985

Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype. Haemophilia 21(1): 124-132, 2015

Rare and unusual bleeding manifestations in congenital bleeding disorders: an annotated review. Clinical and Applied Thrombosis/Hemostasis 18(2): 121-127, 2012

Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders. Thrombosis Research 148(): 128-134, 2016

Central nervous system bleeding in patients with rare bleeding disorders. Haemophilia 18(1): 34-38, 2012

Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia 20 Suppl 4: 71-75, 2014

Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders. Haemophilia 18(4): 630-638, 2012

Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disorders. Clinical and Applied Thrombosis/Hemostasis 20(6): 637-644, 2015